Sign in

CIK 0001812364

  • Large accelerated filer

Relay Therapeutics, Inc.

Sign in to watch
Ticker
RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-370-8837
Business address
60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
  1. 4 Planned sale See remarks sold 42,359 shares at an average $8.34 ($353,071)
  2. 4 Open-market sale President, R&D sold 2,698 shares at $8.85 ($23,877)
  3. 4 Open-market sale Chief Legal Officer sold 1,638 shares at $8.85 ($14,496)
  4. 4 Planned sale President and CEO sold 86,706 shares at an average $9.12 ($790,923)
  5. 4 Grant or award President and CEO acquired 2,108 shares (grant or award)
  6. 4 Open-market sale President, R&D sold 648 shares at $6.26 ($4,056)
  7. 4 Open-market sale See remarks sold 245 shares at $6.26 ($1,534)
  8. 4 Planned sale Chief Financial Officer sold 9,373 shares at an average $6.24 ($58,493)
  9. 4 Open-market sale Chief Legal Officer sold 295 shares at $6.26 ($1,847)
  10. 4 Option exercise Director acquired 42,242 shares (option exercise)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Planned sale See remarks sold 80,909 shares at an average $6.70 ($542,448)
  19. 4 Open-market sale See remarks sold 1,345 shares at $6.38 ($8,581)
  20. 4 Open-market sale Chief Legal Officer sold 1,623 shares at $6.38 ($10,355)

Page 6 of 16 · 320 filings